Glyxambi empagliflozin linagliptin fda approval date 2015?

When did the FDA approve Glyxambi (empagliflozin/linagliptin)?

Glyxambi (empagliflozin + linagliptin) received FDA approval in 2015. [1]

What is Glyxambi, and what drug combination does it contain?

Glyxambi is a fixed-dose combination of:
- Empagliflozin (an SGLT2 inhibitor)
- Linagliptin (a DPP-4 inhibitor) [1]

Where can I verify the exact approval date?

For the FDA approval timing and related drug information, you can check DrugPatentWatch.com. [1]

Sources:
[1] https://www.drugpatentwatch.com/